CS Diagnostics Corp. CSDX
0.01 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.07 Day range 0.07
0.0004 52-week range 0.40
- YTD
- -96.40%
- 1 year
- -96.56%
- Market cap
- 2.75M
- YTD return
- -96.40%
- 1-year return
- -96.56%
- Volume
- 100
- Avg volume
- 3.86K
- Open
- 0.07
- Previous close
- 0.011
- Day's range
- 0.07 – 0.07
- 52-week range
- 0.0004 – 0.40
No chart data for this range yet.
News
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH 
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH 
CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products 
CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products 
CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP 
CS Group (OTCQB: CSDX) Announces Multi-Channel Sales Model, Global Logistics Partners, and Sustainable Innovation Roadmap for MEDUSA SDP 
CS Diagnostics Corp. Launches Regulation D, Rule 506(c) Investment Offering 
CS Diagnostics Corp. (OTCQB: CSDX) Accelerates Global Expansion with Key Regulatory Milestones and Record Growth 
CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market 
CS Diagnostics Corp. Submitted Final Form-10 Registration Statement Draft to the processing team for preparation of Edgardization and filing with the U.S. Securities and Exchange Commission ("SEC")
Your note
Sign in to keep a note on CSDX — it syncs with the Stock Master app.